Cyabra, Inc. Common Stock (CYAB) vs SurgePays, Inc. (SURG)
A side-by-side comparison of Cyabra, Inc. Common Stock and SurgePays, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CYAB
Cyabra, Inc. Common Stock
$0.20TechnologyDelayed quote: Oct 6, 2026, 4:00 PM EDT
SURG
SurgePays, Inc.
$0.15TechnologyDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CYAB vs SURG
growth of $100 · dividends reinvested · last 1yCYAB -98.0% (-98.0%/yr)SURG -82.7% (-82.7%/yr)SURG compounded faster over this window
Log scale — wide-divergence pair
CYAB SURG
CYAB vs SURG: by the numbers
- •CYAB is the larger company ($4M vs $4M market cap).
- •Both run net losses; SURG's is the smaller (-47.89% vs -333.15% net margin).
Metrics side by side
Valuation
| Metric | CYAB | SURG |
|---|---|---|
| P/S ratio | 0.60 | 0.06 |
Profitability
| Metric | CYAB | SURG |
|---|---|---|
| Gross margin | 85.07% | -19.56% |
| Operating margin | -209.74% | -53.69% |
| Net margin | -333.15% | -47.89% |
Growth (annualized)
| Metric | CYAB | SURG |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.61% |
| Total return CAGR (5Y) | N/A | -52.69% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.